aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАН10.52727/2078-256X-2021-17-3-80-81ateroskleroz-519Research ArticleМАТЕРИАЛЫ ВСЕРОССИЙСКОЙ КОНФЕРЕНЦИИ С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «ФУНДАМЕНТАЛЬНЫЕ АСПЕКТЫ АТЕРОСКЛЕРОЗА: НАУЧНЫЕ ИССЛЕДОВАНИЯ ДЛЯ СОВЕРШЕНСТВОВАНИЯ ТЕХНОЛОГИЙ ПЕРСОНАЛИЗИРОВАННОЙ МЕДИЦИНЫ». Г. НОВОСИБИРСК, 15 ОКТЯБРЯ 2021 Г.MATERIALS OF THE RUSSIAN CONFERENCE WITH INTERNATIONAL PARTICIPATION "FUNDAMENTAL ASPECTS OF ATHEROSCLEROSIS: SCIENTIFIC RESEARCH TO IMPROVE THE TECHNOLOGIES OF PERSONALIZED MEDICINE". NOVOSIBIRSK, OCTOBER 15, 2021Уровни MCP-1, IL-6 и генов CCL2, IL6 у мужчин с нестабильными атеросклеротическими бляшкамиСтрюковаЕ. В.
Новосибирск
МаксимовВ. Н.
Новосибирск
ШрамкоВ. С.
Новосибирск
РагиноЮ. И.
Новосибирск
ПолонскаяЯ. В.
Новосибирск
МурашовИ. С.
Новосибирск
КургузовА. В.
Новосибирск
КаштановаЕ. В.
Новосибирск
Научно-исследовательский институт терапии и профилактической медицины – филиал ФГБНУ «Федеральный исследовательский центр Институт цитологии и генетики СО РАН» (в рамках совместных исследований с ФГБУ «Национальный медицинский исследовательский центр им. академика Е.Н. Мешалкина» Минздрава РоссииРоссия2021111020211738081Copyright © Стрюкова Е.В., Максимов В.Н., Шрамко В.С., Рагино Ю.И., Полонская Я.В., Мурашов И.С., Кургузов А.В., Каштанова Е.В., 20212021Стрюкова Е.В., Максимов В.Н., Шрамко В.С., Рагино Ю.И., Полонская Я.В., Мурашов И.С., Кургузов А.В., Каштанова Е.В.Стрюкова Е.В., Максимов В.Н., Шрамко В.С., Рагино Ю.И., Полонская Я.В., Мурашов И.С., Кургузов А.В., Каштанова Е.В.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/519
.
Работа выполнена в рамках бюджетной темы № АААА-А17-117112850280-2 и при финансовой поддержке Правительства Новосибирской областиReferencesAbraham G., Havulinna A. OB-E heart, 2016 U. Genomic prediction of coronary heart disease. academic.oup. com. Accessed April 27, 2020. https://academic.oup.com/eurheartj/article-abstract/37/43/3267/2658448Abraham G., Havulinna A. OB-E heart, 2016 U. Genomic prediction of coronary heart disease. academic.oup. com. Accessed April 27, 2020. https://academic.oup.com/eurheartj/article-abstract/37/43/3267/2658448de Vries M.A., Trompet S., Mooijaart S.P., et al. Complement receptor 1 gene polymorphisms are associated with cardiovascular risk. Atherosclerosis, 2017; 257: 16–21. doi: 10.1016/j.atherosclerosis.2016.12.017de Vries M.A., Trompet S., Mooijaart S.P., et al. Complement receptor 1 gene polymorphisms are associated with cardiovascular risk. Atherosclerosis, 2017; 257: 16–21. doi: 10.1016/j.atherosclerosis.2016.12.017Waksman Ron, Patrick W. Serruys, Schaar J. Handbook of the Vulnerable Plaque. 2nd ed. CRC Press; 2007. Accessed July 13, 2020. https://www.amazon.com/Handbook-Vulnerable-Plaque-Ron-Waksman/dp/184184621XWaksman Ron, Patrick W. Serruys, Schaar J. Handbook of the Vulnerable Plaque. 2nd ed. CRC Press; 2007. Accessed July 13, 2020. https://www.amazon.com/Handbook-Vulnerable-Plaque-Ron-Waksman/dp/184184621XCharo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res., 2004; 95 (9): 858–866. doi: 10.1161/01.RES.0000146672.10582.17Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res., 2004; 95 (9): 858–866. doi: 10.1161/01.RES.0000146672.10582.17Lin J., Kakkar V., Lu X. Impact of MCP-1 in Atherosclerosis. Curr. Pharm. Des., 2014; 20 (28): 4580–4588. doi: 10.2174/1381612820666140522115801Lin J., Kakkar V., Lu X. Impact of MCP-1 in Atherosclerosis. Curr. Pharm. Des., 2014; 20 (28): 4580–4588. doi: 10.2174/1381612820666140522115801Reference SNP (refSNP) Cluster Report: rs1024611 ** With Pathogenic allele **. Accessed September 8, 2020. https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?do_not_redirect&rs=rs1024611Reference SNP (refSNP) Cluster Report: rs1024611 ** With Pathogenic allele **. Accessed September 8, 2020. https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?do_not_redirect&rs=rs1024611Rovin B.H., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun., 1999; 259 (2): 344–348. doi: 10.1006/bbrc.1999.0796Rovin B.H., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun., 1999; 259 (2): 344–348. doi: 10.1006/bbrc.1999.0796Cai G., Zhang B., Weng W., Shi G., Huang Z. The associations between the MCP-1 –2518 A/G polymorphism and ischemic heart disease and ischemic stroke: A meta-analysis of 28 research studies involving 21,524 individuals. Mol. Biol. Rep., 2015; 42 (5): 997–1012. doi: 10.1007/s11033-014-3836-8Cai G., Zhang B., Weng W., Shi G., Huang Z. The associations between the MCP-1 –2518 A/G polymorphism and ischemic heart disease and ischemic stroke: A meta-analysis of 28 research studies involving 21,524 individuals. Mol. Biol. Rep., 2015; 42 (5): 997–1012. doi: 10.1007/s11033-014-3836-8Schuett H., Luchtefeld M., Grothusen C., Grote K., Schieffer B. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thrombosis and Haemostasis, 2009; 102: 215–222. doi: 10.1160/TH09-05-0297Schuett H., Luchtefeld M., Grothusen C., Grote K., Schieffer B. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thrombosis and Haemostasis, 2009; 102: 215–222. doi: 10.1160/TH09-05-0297Hartman J., Frishman W.H. Inflammation and atherosclerosis: A review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol. Rev., 2014; 22 (3): 147–151. doi: 10.1097/CRD.0000000000000021Hartman J., Frishman W.H. Inflammation and atherosclerosis: A review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol. Rev., 2014; 22 (3): 147–151. doi: 10.1097/CRD.0000000000000021Reference SNP (refSNP) Cluster Report: rs1800795 **Clinical Channel**. Accessed September 8, 2020. https://www.ncbi.nlm.nih.gov/projects/SNP/ snp_ref.cgi?do_not_redirect&rs=rs 1800795Reference SNP (refSNP) Cluster Report: rs1800795 **Clinical Channel**. Accessed September 8, 2020. https://www.ncbi.nlm.nih.gov/projects/SNP/ snp_ref.cgi?do_not_redirect&rs=rs 1800795Li Y.Y., Zhou C.W., Xu J., Qian Y., Wang X.M. Interleukin-6 C-572G gene polymorphism and coronary artery disease in asian: A meta-analysis of 2511 subjects. Int. J. Clin. Exp. Med., 2015; 8 (6): 8995–9003. Accessed September 8, 2020. https://pubmed.ncbi.nlm.nih.gov/26309552/Li Y.Y., Zhou C.W., Xu J., Qian Y., Wang X.M. Interleukin-6 C-572G gene polymorphism and coronary artery disease in asian: A meta-analysis of 2511 subjects. Int. J. Clin. Exp. Med., 2015; 8 (6): 8995–9003. Accessed September 8, 2020. https://pubmed.ncbi.nlm.nih.gov/26309552/Rizzello V., Liuzzo G., Trabetti E., et al. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J. Cardiovasc. Med., 2010; 11 (1): 20–25. doi: 10.2459/JCM.0b013e328330e9fbRizzello V., Liuzzo G., Trabetti E., et al. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J. Cardiovasc. Med., 2010; 11 (1): 20–25. doi: 10.2459/JCM.0b013e328330e9fbDietel B., Cicha I., Voskens C.J., Verhoeven E., Achenbach S., Garlichs C.D. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis, 2013; 230 (1): 92–99. doi: 10.1016/j.atherosclerosis. 2013.06.014Dietel B., Cicha I., Voskens C.J., Verhoeven E., Achenbach S., Garlichs C.D. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis, 2013; 230 (1): 92–99. doi: 10.1016/j.atherosclerosis. 2013.06.014Niu W., Liu Y., Qi Y., et al. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach. Elsevier. Accessed April 27, 2020. https://www.sciencedirect.com/science/article/pii/S0167527311022790Niu W., Liu Y., Qi Y., et al. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach. Elsevier. Accessed April 27, 2020. https://www.sciencedirect.com/science/article/pii/S0167527311022790
The authors declare that there are no conflicts of interest present.